IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 222 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,291,785 | +504.1% | 2,210,985 | +566.8% | 0.24% | +505.1% |
| Q2 2023 | $3,524,738 | -22.3% | 331,584 | -23.1% | 0.04% | -38.1% |
| Q1 2023 | $4,536,929 | +50.3% | 431,267 | +77.1% | 0.06% | +43.2% |
| Q4 2022 | $3,017,919 | +0.5% | 243,577 | -16.0% | 0.04% | -4.3% |
| Q3 2022 | $3,004,000 | -87.7% | 290,002 | -86.3% | 0.05% | -86.5% |
| Q2 2022 | $24,344,000 | +3.1% | 2,109,530 | +12.4% | 0.34% | +22.1% |
| Q1 2022 | $23,609,000 | +17.3% | 1,876,727 | +9.1% | 0.28% | +26.7% |
| Q4 2021 | $20,135,000 | +0.3% | 1,720,956 | +11.9% | 0.22% | -2.6% |
| Q3 2021 | $20,077,000 | +0.9% | 1,537,262 | -0.7% | 0.23% | +10.7% |
| Q2 2021 | $19,900,000 | +308.7% | 1,547,452 | +255.3% | 0.20% | +327.1% |
| Q1 2021 | $4,869,000 | +1.3% | 435,529 | +3.1% | 0.05% | 0.0% |
| Q4 2020 | $4,806,000 | +1075.1% | 422,348 | +828.4% | 0.05% | +1100.0% |
| Q3 2020 | $409,000 | – | 45,491 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |